| Janssen-Cilag AG - Prezista 100 mg/ml, orale Suspension | | 65381 | | 01 | | Prezista 100 mg/ml | | orale Suspension | | J05AE10 | | Darunavir | | 23.07.2015 | | |
| | Composition | | darunavirum 100 mg ut darunavirum ethanolum, hydroxypropylcellulosum, cellulosum microcristallinum, carmellosum natricum, acidum citricum monohydricum, sucralosum, acidum hydrochloridum concentratum, aromatica (Geschmacksüberdeckungsaroma), aromatica (Erdbeer), E 219 3.43 mg, aqua purificata ad suspensionem pro 1 ml corresp. natrium 570 µg. | | Packungsbestandteile | | Suspension (orale) | | | | | | Principe actif | Concentr. |
|---|
| Darunavir | 100 mg/ml |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acide Citrique Monohydre | | | | Acidum Hydrochloridum Concentratum | | | | Aromatica (Erdbeer) | | | | Aromatica (Geschmacksüberdeckungsaroma) | | | | Carmellose Sodique | | | | Cellulosum Microcristallinum | | | | E 219 | 3.43 mg/ml | conserv. | | Hydroxypropylcellulosum | | | | Sucralosum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | flacon(s) | DDP | DDP | A | | Oui |
|
|
